In addition, and importantly, a decrease in LRG1 was related to response and LDA to biologics treatment in RA patients and tended to be related to remission (not statistically significant), indicating the potential of LRG1 as a prognostic marker for biologics in RA patients. Here, LRG1 is linked to rheumatoid arthritis.